AU6211680A - 2-amino-3-benzoyl-phenylacetamides - Google Patents

2-amino-3-benzoyl-phenylacetamides

Info

Publication number
AU6211680A
AU6211680A AU62116/80A AU6211680A AU6211680A AU 6211680 A AU6211680 A AU 6211680A AU 62116/80 A AU62116/80 A AU 62116/80A AU 6211680 A AU6211680 A AU 6211680A AU 6211680 A AU6211680 A AU 6211680A
Authority
AU
Australia
Prior art keywords
phenylacetamides
benzoyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU62116/80A
Other versions
AU532359B2 (en
Inventor
Dwight Allan Shamblee
James Robert Shanklin
David Allan Walsh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AH Robins Co Inc
Original Assignee
AH Robins Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AH Robins Co Inc filed Critical AH Robins Co Inc
Publication of AU6211680A publication Critical patent/AU6211680A/en
Application granted granted Critical
Publication of AU532359B2 publication Critical patent/AU532359B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU62116/80A 1979-09-26 1980-09-08 2-amino-3-benzoyl-phenylacetamides Ceased AU532359B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7886079A 1979-09-26 1979-09-26
US078860 1979-09-26

Publications (2)

Publication Number Publication Date
AU6211680A true AU6211680A (en) 1981-04-02
AU532359B2 AU532359B2 (en) 1983-09-29

Family

ID=22146633

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62116/80A Ceased AU532359B2 (en) 1979-09-26 1980-09-08 2-amino-3-benzoyl-phenylacetamides

Country Status (36)

Country Link
JP (1) JPS5657751A (en)
KR (1) KR840000763B1 (en)
AT (1) AT374170B (en)
AU (1) AU532359B2 (en)
BE (1) BE885393A (en)
BR (1) BR8006042A (en)
CA (1) CA1128512A (en)
CH (1) CH646138A5 (en)
CS (1) CS227012B2 (en)
DE (1) DE3035688A1 (en)
DK (1) DK154136C (en)
EG (1) EG15020A (en)
ES (2) ES495329A0 (en)
FI (1) FI72967C (en)
FR (1) FR2465710A1 (en)
GB (1) GB2059963B (en)
GR (1) GR70049B (en)
HK (1) HK59383A (en)
HU (1) HU183215B (en)
IE (1) IE50268B1 (en)
IL (1) IL60999A (en)
IN (3) IN151313B (en)
IT (1) IT1133823B (en)
KE (1) KE3307A (en)
LU (1) LU82797A1 (en)
MX (1) MX7159E (en)
NL (1) NL8005346A (en)
NO (1) NO152128C (en)
NZ (1) NZ195061A (en)
PH (1) PH22628A (en)
PL (1) PL128998B1 (en)
PT (1) PT71839B (en)
SE (1) SE448626B (en)
SG (1) SG42983G (en)
YU (3) YU41734B (en)
ZA (1) ZA805476B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61945A (en) * 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US6646001B2 (en) 1997-12-19 2003-11-11 Alcon Manufacturing, Ltd. Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
GB9727523D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
AR030345A1 (en) * 2000-08-14 2003-08-20 Alcon Inc METHOD OF TREATMENT OF DISORDERS RELATED TO ANGIOGENESIS
PT1423168E (en) 2001-09-03 2006-05-31 Newron Pharm Spa PHARMACEUTICAL COMPOSITION WHICH UNDERSTAND GABAPENTINE OR ITS ANALOGUE AND AN X-AMINOAMIDE AND ITS USE AS ANALGESIC
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
CZ2009367A3 (en) * 2009-06-08 2010-06-16 Farmak, A.S. Process for preparing 2-amino-3-benzoylphenylacetamide (nepafenac) with minimum of by-products
CN112794809B (en) * 2019-11-14 2023-12-29 南京济群医药科技股份有限公司 Preparation method of high-purity nepafenac intermediate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226344A (en) * 1967-07-31 1971-03-24
SE400966B (en) * 1975-08-13 1978-04-17 Robins Co Inc A H PROCEDURE FOR PREPARING 2-AMINO-3- (OR 5-) BENZOYL-PHENYLETIC ACIDS
IL61945A (en) * 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GR70049B (en) 1982-07-26
KE3307A (en) 1983-08-19
DK154136B (en) 1988-10-17
ES8200329A1 (en) 1981-10-16
HU183215B (en) 1984-04-28
DK405780A (en) 1981-03-27
FR2465710B1 (en) 1984-10-12
IL60999A (en) 1984-05-31
YU43306B (en) 1989-06-30
IE801946L (en) 1981-03-26
YU73183A (en) 1983-12-31
JPS5657751A (en) 1981-05-20
NZ195061A (en) 1984-04-27
JPH0141616B2 (en) 1989-09-06
LU82797A1 (en) 1982-05-10
BR8006042A (en) 1981-04-07
ES8204715A1 (en) 1982-05-01
FI72967B (en) 1987-04-30
IN151313B (en) 1983-03-26
NL8005346A (en) 1981-03-30
KR840000763B1 (en) 1984-06-08
CH646138A5 (en) 1984-11-15
NO152128B (en) 1985-04-29
FI72967C (en) 1987-08-10
IL60999A0 (en) 1980-11-30
YU41734B (en) 1987-12-31
ES503019A0 (en) 1982-05-01
HK59383A (en) 1983-12-02
AU532359B2 (en) 1983-09-29
NO152128C (en) 1985-08-07
PL128998B1 (en) 1984-03-31
GB2059963A (en) 1981-04-29
YU245080A (en) 1983-09-30
IT1133823B (en) 1986-07-24
FR2465710A1 (en) 1981-03-27
EG15020A (en) 1985-03-31
YU73083A (en) 1983-12-31
IE50268B1 (en) 1986-03-19
DE3035688A1 (en) 1981-04-16
DK154136C (en) 1989-03-06
GB2059963B (en) 1983-04-20
SE8006668L (en) 1981-03-27
YU43305B (en) 1989-06-30
MX7159E (en) 1987-12-02
ES495329A0 (en) 1981-10-16
FI803002A (en) 1981-03-27
SG42983G (en) 1985-01-11
IN156254B (en) 1985-06-08
IT8024948A0 (en) 1980-09-26
AT374170B (en) 1984-03-26
KR830004210A (en) 1983-07-06
NO802834L (en) 1981-03-27
BE885393A (en) 1981-01-16
PH22628A (en) 1988-10-28
PL226919A1 (en) 1982-02-01
IN156255B (en) 1985-06-08
PT71839B (en) 1981-06-25
PT71839A (en) 1980-10-01
DE3035688C2 (en) 1990-05-17
CS227012B2 (en) 1984-04-16
ATA474580A (en) 1983-08-15
CA1128512A (en) 1982-07-27
SE448626B (en) 1987-03-09
ZA805476B (en) 1981-11-25

Similar Documents

Publication Publication Date Title
AU532879B2 (en) 1-aryl-2-acylamido-3-fluoro-1-propanols
AU548070B2 (en) Arylsulphonyls
AU532626B2 (en) Monacolink
AU541091B2 (en) Azolyloxy-carboxylic acid -oxy-amides
AU532090B2 (en) Emmitter
AU532783B2 (en) 4-aroyl-imazol-2-ones
AU535632B2 (en) Cyclo-octapeptides
AU537592B2 (en) Mercaptoacyldipeptides
AU529508B2 (en) 6-n-propyl-8alpha-methoxymethyl or -methylmercaptomethyl -ergolines
AU533526B2 (en) Polyether-polyamines
AU525431B2 (en) Emulsans
AU532884B2 (en) Vinyl-cephalosporins
AU528665B2 (en) Breathalyser
AU527992B2 (en) 9-aminoalkylfluorenes
AU532763B2 (en) 8-aminoalkyl-4-alkylpsoralens
AU539187B2 (en) Pyrazinobenzodiazepines
AU538025B2 (en) N-cyanoimidate
AU531808B2 (en) Tetrahydrobenzothiazolylimidazolidinones
AU531811B2 (en) Thiazolylidene-oxo-propionitriles
AU532359B2 (en) 2-amino-3-benzoyl-phenylacetamides
AU532700B2 (en) Diphenylalkanoether
AU536556B2 (en) Aldehyde-ethers
AU538686B2 (en) 1-substituted-2-pyrrolidinones
AU541869B2 (en) 10-halo-e-homo eburnanes
AU535376B2 (en) N-oximinoalkyl-anilides